Iron deficiency appears as the most frequent cause of failure to respond to treatment with EPO; however, it must not be forgotten that active inflammatory or infectious processes can temporarily block the response to iron therapy and therefore, to EPO [12–14]. The gene discussed is EPO; the disease is Iron deficiency anemia.